NYSE:NGVT Ingevity (NGVT) Stock Price, News & Analysis $68.89 +0.69 (+1.01%) As of 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Ingevity Stock (NYSE:NGVT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Ingevity alerts:Sign Up Key Stats Today's Range$67.71▼$69.5650-Day Range$66.95▼$77.7952-Week Range$45.85▼$79.29Volume226,394 shsAverage Volume286,658 shsMarket Capitalization$2.37 billionP/E Ratio46.86Dividend YieldN/APrice Target$80.00Consensus RatingHold Company Overview Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company that develops products designed to improve performance, sustainability and resource efficiency across a range of industrial and consumer applications. Its businesses serve automotive, infrastructure, industrial, agricultural and other end markets. The company’s portfolio includes activated carbon products used in vehicle evaporative-emissions control systems, industrial air and water purification, and other filtration applications. Ingevity also produces specialty chemicals derived in part from renewable raw materials, including materials used in adhesives, coatings, pavement and asphalt technologies, agricultural chemicals and other formulated products. Ingevity is headquartered in North Charleston, South Carolina, and serves customers in the United States and international markets. The company was formed in 2016 through the spin-off of the specialty chemicals business of WestRock, which combined operations formerly associated with MeadWestvaco. Its products are manufactured and marketed through facilities and commercial operations serving customers globally.AI Generated. May Contain Errors. Read More Ingevity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks42nd Percentile Overall ScoreNGVT MarketRank™: Ingevity scored higher than 42% of companies evaluated by MarketBeat, and ranked 172nd out of 226 stocks in the materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.7 / 5Analyst RatingHold Consensus RatingIngevity has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and no sell ratings.Upside PotentialIngevity has a consensus price target of $80.00, representing about 15.7% upside from its current price of $69.13.Amount of Analyst CoverageIngevity has only been the subject of 1 research reports in the past 90 days.Read more about Ingevity's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth9.26% Earnings GrowthEarnings for Ingevity are expected to grow by 9.26% in the coming year, from $5.40 to $5.90 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ingevity is 47.03, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.07.Price to Earnings Ratio vs. SectorThe P/E ratio of Ingevity is 47.03, which means that it is trading at a more expensive P/E ratio than the Materials sector average P/E ratio of about 26.00.Price to Book Value per Share RatioIngevity has a P/B Ratio of 83.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Ingevity's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.86% of the float of Ingevity has been sold short.Short Interest Ratio / Days to CoverIngevity has a short interest ratio ("days to cover") of 6.15.Change versus previous monthShort interest in Ingevity has recently increased by 5.21%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIngevity does not currently pay a dividend.Dividend GrowthIngevity does not have a long track record of dividend growth. News and Social Media2.4 / 5News Sentiment0.76 News SentimentIngevity has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Materials companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Ingevity this week, compared to 2 articles on an average week. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Ingevity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,347,481.00 in company stock.Percentage Held by Insiders0.88% of the stock of Ingevity is held by insiders.Percentage Held by Institutions91.59% of the stock of Ingevity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Ingevity's insider trading history. Receive NGVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NGVT Stock News HeadlinesIngevity CEO Dave Li to speak at 2026 Water Tower Research Insights ConferenceSeptember 17, 2026 | finance.yahoo.comIs Ingevity (NGVT) Stock Outpacing Its Basic Materials Peers This Year?September 15, 2026 | finance.yahoo.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.September 21 at 1:00 AM | Banyan Hill Publishing (Ad)Ingevity: Portfolio Simplification Reveals A High-Margin Regulatory CompounderAugust 28, 2026 | seekingalpha.comIngevity Corporation (NGVT) Q2 2026 Earnings Call TranscriptJuly 30, 2026 | seekingalpha.comIngevity's Q2 Adjusted Earnings Increase, Net Sales Decline; 2026 Adjusted EPS Outlook RaisedJuly 30, 2026 | finance.yahoo.comIngevity Corporation 2026 Q2 - Results - Earnings Call PresentationJuly 30, 2026 | seekingalpha.comIngevity: Q2 Earnings SnapshotJuly 29, 2026 | finance.yahoo.comSee More Headlines NGVT Stock Analysis - Frequently Asked Questions How have NGVT shares performed this year? Ingevity's stock was trading at $59.22 at the start of the year. Since then, NGVT stock has increased by 16.7% and is now trading at $69.13. How were Ingevity's earnings last quarter? Ingevity Corporation (NYSE:NGVT) released its quarterly earnings results on Wednesday, July, 29th. The company reported $1.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.41. The company had revenue of $314.10 million for the quarter, compared to analyst estimates of $312.20 million. Ingevity had a trailing twelve-month return on equity of 284.70% and a net margin of 4.65%. Read the conference call transcript. Who are Ingevity's major shareholders? Ingevity's top institutional investors include BlackRock Inc. (15.60%), Wellington Management Group LLP (3.13%), Rice Hall James & Associates LLC (1.02%) and Bank of America Corp DE (0.92%). Insiders that own company stock include David H Li, Ryan C Fisher and Terrance M Dyer. View institutional ownership trends. How do I buy shares of Ingevity? Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Ingevity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ingevity investors own include American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), Humana (HUM), AUO (AUOTY), The RMR Group (RMR) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings7/29/2026Today9/21/2026Water Tower Research Virtual Insights Conference9/23/2026Next Earnings (Estimated)11/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (10m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 NGVT's financial health is in the Green zone, according to TradeSmith. NGVT has been in this zone for over 10 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMaterials Industry Chemicals Sub-IndustrySpecialty Chemicals Current SymbolNYSE:NGVT Previous SymbolNASDAQ:NGVT CIK1653477 Webwww.ingevity.com Phone(843) 740-2300Fax843-740-8165Employees1,500Year Founded2015Price Target and Rating Average Price Target for Ingevity$80.00 High Price Target$83.00 Low Price Target$75.00 Potential Upside/Downside+16.1%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$1.47 Trailing P/E Ratio46.86 Forward P/E Ratio12.76 P/E GrowthN/ANet Income-$167.10 million Net Margins4.65% Pretax Margin3.26% Return on Equity284.70% Return on Assets10.82% Debt Debt-to-Equity Ratio22.52 Current Ratio1.61 Quick Ratio1.15 Sales & Book Value Annual Sales$1.17 billion Price / Sales2.03 Cash Flow$12.41 per share Price / Cash Flow5.55 Book Value$0.83 per share Price / Book83.00Miscellaneous Outstanding Shares34,380,000Free Float34,075,000Market Cap$2.37 billion OptionableOptionable Beta1.17 Social Links 10 Best Stocks to Own - Fall 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NYSE:NGVT) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ingevity Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Ingevity With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.